89658354

  • Upload
    henry72

  • View
    214

  • Download
    0

Embed Size (px)

Citation preview

  • 7/29/2019 89658354

    1/11

    Article

    A 90-day subchronic toxicity studyof neem oil, a Azadirachta indica oil,in mice

    C. Wang1, M. Cao2, D-X. Shi1, Z-Q. Yin1, R-Y. Jia1,K-Y. Wang1, Y. Geng1, Y. Wang1, X-P. Yao1,

    Z-R. Yang3 and J. Zhao3

    Abstract

    To determine the no-observed-adverse-effect level (NOAEL) of exposure and target organs of neem oil forestablishing safety criteria for human exposure, the subchronic toxicity study with neem oil in mice wasevaluated. The mice (10 per sex for each dose) was orally administered with neem oil with the doses of 0

    (to serve as a control), 177, 533 and 1600 mg/kg/day for 90 days. After the treatment period, observationof reversibility or persistence of any toxic effects, mice were continuously fed without treatment for the fol-lowing 30 days. During the two test periods, the serum biochemistry, organ weight and histopathology wereexamined. The results showed that the serum biochemistry and organ coefficient in experimental groups hadno statistical difference compared with those of the control group. At the 90th day, the histopathologicalexaminations showed that the 1600 mg/kg/day dose of neem oil had varying degrees of damage on each organexcept heart, uterus and ovarian. After 30-day recovery, the degree of lesions to the tissues was lessened oreven restored. The NOAEL of neem oil was 177 mg/kg/day for mice and the target organs of neem oil weredetermined to be testicle, liver and kidneys.

    Keywords

    Azadirachta indica oil; neem oil; subchronic toxicity; mice

    Introduction

    Neem (Azadirachta indica) has been accepted univer-

    sally as a wonder tree in India.1 Neem oil, also

    called Margosa oil, is an extract from seeds or fruits

    of A. indica obtained through pressing or solvent

    extraction. Neem oil was widely used as a traditionalmedicine by Indians in India, Sri Lanka, Burma,

    Thailand, Malaysia and Indonesia and already has

    more than 2000 years of history. It is used mainly forexternal applications and was often administered orally

    for deworming, leprosy, constipation, rheumatism,

    ulcer, relieve itching and chronic skin diseases.2,3 It

    contains mostly long- and medium-chain fatty acids

    (8095%) and volatile sulfur compounds (420%) as

    well as a number of bioactive compounds, such as nim-

    bin, nimbidin and nimbinin,4,5 that have been demon-

    strated to have biocidal activity against nearly 200

    medical and veterinary arthropods, without any

    adverse effects toward most nontarget organisms.6,7

    It was also found to have acaricidal, antibacterial, anti-

    fungal, antimalarial, antiparasitic, anti-inflammatory,

    promotion of wound healing and immunomodulatory

    properties in different animal species.1,5,713

    Our previous research showed that the median lethal

    dose (LD50) of extract chloroform isolated from neem

    oil in Sprague Dawley rats was above 10,000 mg/

    1 College of Veterinary Medicine, Sichuan Agricultural University,

    Yaan, China2 Core Laboratory, Sichuan Academy of Medical Sciences &

    Sichuan Provincial Peoples Hospital, Chengdu, China3 Key Laboratoryof Biological Resource and Ecological Environment

    of Chinese Education Ministry, College of Life Science, Sichuan

    University, Chengdu, China

    Corresponding author:

    Zhong-Qiong Yin, College of Veterinary Medicine, Sichuan

    Agricultural University, Yaan 625014, China.Email: [email protected]

    Human and Experimental Toxicology

    32(9) 904913

    The Author(s) 2013

    Reprints and permission:

    sagepub.co.uk/journalsPermissions.nav

    DOI: 10.1177/0960327113475677

    het.sagepub.com

    http://www.sagepub.co.uk/journalsPermissions.navhttp://het.sagepub.com/http://het.sagepub.com/http://www.sagepub.co.uk/journalsPermissions.nav
  • 7/29/2019 89658354

    2/11

    kg,14 the LD50 of neem oil in mice was 31,950 mg/kg,

    theaccumulative coefficient (K)wasabove5,ithadlow

    toxic effects.15 The present study was thereby per-

    formed to evaluate the subchronic toxicity of neem oil

    according to the OECD test guideline 408 for

    Repeated dose 90-day oral toxicity study in rodents

    except for the lack of ophthalmological examinationand functional observations during feeding experi-

    ment.16 The study will provide information on the

    major toxic effects, indicate target organs, and can pro-

    vide an estimate of a no-observed-adverse-effect level

    (NOAEL) of neem oil, and provide information on the

    possible health hazards likely to arise from people

    repeated exposure over a prolonged period of time.

    Materials and methods

    Plant materialNeem oil that was extracted from the seeds of the

    neem (A. indica) using carbon dioxide supercritical

    fluid extraction was supplied by a pesticide company

    (Green Gold Biological Science & Technology Co.

    Ltd, Chengdu, PR China). All chemicals we used in

    the test were of analytical grade (>99.7%).

    Animals and treatments

    Kunming strain male and female mice (a closed

    strain coming from Kunming, Yunnan Province,

    PR China) were obtained from the Chengdu Dossy

    Experimental Animals Co., Ltd (Sichuan provence,

    Chengdu, P.R. China, License No.SCXK (Sichuan)

    2008-24), weighing 1315 g, kept at room tempera-

    ture of 22C. Mice were fed with a standard diet

    from Nuvital Nutrientes (Colombo/PR, Brazil) and

    allowed free access to water and have been accli-

    mated to laboratory conditions for 7 days.

    Three groups of 20 mice, each containing 10

    females and 10 males, received a daily dose of

    177 mg/kg of body weight (b.w.; group II), 533 mg/

    kg b.w. (group III) and 1600 mg/kg b.w. (group IV)of neem oil mixed with 1% carboxymethyl cellulose

    sodium, a vehicle-control group (group I) formed by

    20 mice received a daily dose of 533 mg/kg b.w. of

    1% carboxymethyl cellulose sodium during a

    90-day period. In each case, the product volume admi-

    nistered by gavage was 2 mL/100 g b.w. Each mouse

    was marked with a unique identification number

    using trinitrophenol. Body weight was measured once

    a week and the behavior was observed daily during

    the trial period. At the end of the treatment, mice were

    continuously fed without treatment for 30 days to

    detect persistence of or recovery from toxic effects.

    Clinical biochemistry analyses

    At the end of experimentation (the 90th and 120thday), half of the total amount of mice per sex, respec-

    tively, underwent overnight fasting prior to collection

    of the blood sample. Blood of each mouse wascollected by retro-orbital bleeding and subjected to

    clinical biochemical tests. For the hepatic function,

    serum alkaline phosphatase, alanine aminotransferase

    and aspartate aminotransferase were determined,

    while for the renal function, serum urea nitrogen and

    serum creatinine were evaluated. Serum glucose was

    accessed for carbohydrate metabolism analysis. Total

    protein, albumin, globulin, albumin/globulin ratio (A/

    G), total bilirubin and cholesterol were also measured.All these biochemical parameters were determined as

    described previously by Lincopan et al.17

    Organic coefficient and histopathological analysis

    On the 90th day and 120th day after blood collection

    for biochemical analysis, all the animals were eutha-

    nized, detailed gross necropsy was carefully exam-

    ined. Extracted heart, liver, spleen, lungs and doublekidneys were trimmed of any adherent tissue, their

    wet weight taken as soon as possible after dissectionto avoid drying to cipher organic coefficient (ratio

    of organ weight to body weight was calculated). The

    principal vital organs (heart, liver, spleen, lung,

    kidney, testis, ovary and uterus) were preserved in

    fixation medium of 10% solution of buffered formalin

    (pH 7.4) and enclosed in paraffin-intended subsequent

    histopathological examination. A section of each

    organ tissue of 5 mm was stained with hematoxylin

    and eosin (H&E). Each section was examined under

    an optical microscope.

    Statistic evaluation

    All results were expressed as mean + SD (x s) for

    the indicated number of experiments. The signifi-

    cance of the difference among groups was analyzed

    using one-way analysis of variance followed by the

    StudentNewmanKeuls test. All statistic analyses

    were made using the statistical analysis software

    SPSS 17.0. The significant values at either p < 0.05

    (*) or p < 0.01 (**) were represented as asterisks.

    Wang C. et al. 905

  • 7/29/2019 89658354

    3/11

    Results

    General observation, effects on clinical signs and

    food consumption

    There was no treatment-related mortality in animals

    treated with neem oil for 90 days at any dose tested.

    The group at the dose of 1600 mg/kg/day showed

    treatment-related clinical signs, such as rough fur and

    loss of appetite in the last 2 weeks. No treatment-

    related clinical signs were observed in other experi-

    mental groups.

    The food consumption result is shown in Table 1.

    The food consumption of all the test groups had no

    statistical difference compared with that of the con-

    trol group in month 1 and recovery month (p > 0.05),

    while that of the dose 1600 mg/kg/day group was

    very significantly decreased in months 2 and 3

    (p < 0.01).

    Table 1. Food consumption (g/100 g) of mice treated with neem oil.a

    Groups Doses (mg/kg)

    Food consumption of mice within 4 months postadministration

    Month 1 Month 2 Month 3 Recovery month

    Group I 0 11.56 + 1.71 9.20 + 2.53 8.43 + 1.67 8.81 + 1.72

    Group II 177 10.88 + 1.34 8.13 + 2.31 7.29 + 2.80 7.80 + 2.09Group III 533 10.51 + 1.30 8.45 + 2.88 7.31 + 0.76 7.70 + 1.44Group IV 1600 9.09 + 2.53 5.43 + 0.64bc 4.90 + 0.52bc 7.08 + 0.87

    ANOVA: analysis of variance.aData shown as mean + SD were analyzed by ANOVA followed by SPSS 17.0.bSignificantly different from control p < 0.01.cSignificantly different from control p < 0.05.

    Table 2. Serum biochemistry parameters of mice treated with neem oil.a

    Groups Doses (mg/kg) TP (g/L) ALB (g/L) GLO (g/L) A/G TBIL (mmol/L) ALT (U/L)

    Administration for 90 days

    Group I 0 74.87 + 5.43 47.20 + 4.99 27.67 + 0.45 1.73+ 0.15 12.63 + 4.64 135 + 2.15Group II 177 71.17 + 2.04 43.93 + 2.90 27.23 + 2.22 1.43+ 0.42 16.85 + 3.70 214 + 1.78Group III 533 76.80 + 0.80 44.67 + 5.67 32.13 + 4.87 2.20+ 0.11 18.74 + 6.87 147 + 3.77Group IV 1600 80.07 + 9.07 50.60 + 8.28 29.47 + 1.86 1.73+ 0.15 14.78 + 6.45 160 + 7.64After 30-day recoveryGroup I 0 66.57 + 3.10 41.53 + 3.73 25.03 + 1.21 1.63+ 0.23 15.12 + 4.35 103 + 7.52Group II 177 73.07 + 5.04 45.17 + 7.06 27.90 + 2.52 1.63+ 0.38 14.85 + 3.55 121 + 7.64Group III 533 71.37 + 3.25 41.73 + 1.34 29.63 + 3.34 1.40+ 0.17 18.96 + 6.40 95 + 7.07Group IV 1600 67.00 + 3.34 38.93 + 5.34 28.07 + 5.69 1.43+ 0.51 19.11 + 7.04 86 + 9.40

    Groups Doses (mg/kg) AST (U/L) GLU (mmol/L) CHO (mmol/L) AST/ALT BUN (mmol/L) CRE (mmol/L)

    Administration for 90 days

    Group I 0 570 + 49.96 8.34+ 1.15 3.37 + 0.94 4.60+ 1.68 26.84 + 1.71 65.19 + 1.04Group II 177 300 + 22.63 9.05+ 1.72 3.05 + 0.37 4.90+ 1.02 19.85 + 0.82 55.70 + 1.78Group III 533 473 + 87.17 7.29+ 0.90 2.82 + 0.08 3.47+ 1.56 22.74 + 0.60 62.77 + 2.04Group IV 1600 570 + 57.09 8.78+ 0.85 3.53 + 0.53 4.07+ 2.25 26.95 + 2.21 74.26 + 0.85After 30-day recoveryGroup I 0 449 + 92.36 7.72+ 0.74 2.74 + 0.88 4.67+ 1.68 20.79 + 0.71 54.62 + 4.10Group II 177 526 + 32.18 6.40+ 1.00 2.08 + 0.37 4.07 + 2.24 22.70 + 0.15 61.89 + 2.80Group III 533 475 + 37.21 7.58+ 0.27 2.26 + 0.43 4.97 + 1.03 25.94 + 0.54 55.70 + 3.04Group IV 1600 411 + 31.52 9.73+ 1.89 2.48 + 0.43 4.70+ 0.85 23.49 + 1.98 55.69 + 2.00

    ALT: alanine aminotransferase; AST: aspartate aminotransferase; BUN: urea nitrogen***; CRE: creatinine; GLU: glucose; TP: totalprotein; ALB: albumin; GLO: globulin; TBIL: total bilirubin; CHO: cholesterol; ANOVA: analysis of variance.aData shown as mean + SD were analyzed by ANOVA followed by SPSS 17.0.No significant difference from the control group at p > 0.05.

    906 Human and Experimental Toxicology 32(9)

  • 7/29/2019 89658354

    4/11

    Table 3. Organic coefficient (g/100 g) of mice treated with neem oil.a

    Groups Doses (mg/kg) Heart Live Spleen Lung Kidney

    Administration for 90 daysGroup I 0 0.54 + 0.15 4.67 + 0.86 0.28 + 0.03 0.88 + 0.25 1.34 + 0.21Group II 177 0.47 + 0.14 4.18 + 0.57 0.29 + 0.04 0.89 + 0.76 1.32 + 0.42

    Group III 533 0.50 + 0.16 4.54 + 0.75 0.34 + 0.12 0.81 + 0.19 1.21 + 0.16Group IV 1600 0.49 + 0.18 4.31 + 0.47 0.23 + 0.06 0.76 + 0.15 1.23 + 0.41After 30-day recoveryGroup I 0 0.46 + 0.30 4.50 + 0.71 0.25 + 0.02 0.76 + 0.13 1.21 + 0.35Group II 177 0.47 + 0.37 4.18 + 0.53 0.30 + 0.03 0.68 + 0.15 1.25 + 0.16Group III 533 0.51 + 0.24 4.99 + 0.68 0.26 + 0.07 0.62 + 0.05 1.12 + 0.13Group IV 1600 0.46 + 0.10 4.99 + 0.45 0.27 + 0.07 0.73 + 0.32 1.37 + 0.46

    ANOVA: analysis of variance.aData shown as mean + SD were analyzed by ANOVA followed by SPSS 17.0.No significant difference from the control group at P > 0.05.

    (a)

    Si

    BDHA

    H

    P V

    (b)

    Si

    (d)

    CV

    CV

    K

    (c)

    CV

    Si

    Figure 1. Effect of neem oil on the microstructures of liver of mice after administration for 90 days. Panel A: group I(0 mg/kg, HE 200); panel B: group II (177 mg/kg, HE 400); panel C: group III (533 mg/kg, HE 400); Panel D: group IV(1600 mg/kg, HE 400). Photomicrographs of the liver from mice treated with 0, 177, 533 and 1600 mg/kg in a 90-daysubchronic oral toxicity evaluation of neem oil. Cross-sections were stained with hematoxylin and eosin. Observationwas made at different amplified levels. Group I, the cross-section showed the normal appearance of liver, hepatic artery,portal vein, bile duct, Sis, Hs, all clearly conserved. Groups II and III, showed central venous (CV) and Sis congestion in liverlobule (!); group IV, central venous congestion (!), granular and vacuolar degeneration ("), karyorrhexis (K) wereobserved in Hs. Si: sinusoid; H: hepatocyte.

    Wang C. et al. 907

  • 7/29/2019 89658354

    5/11

    Biochemical examination

    The serum biochemistry parameters were examined

    after 90 days of oral administration with neem oil.

    No significant differences were noted between the

    mice-treated groups with the 177, 533 and 1600 mg/

    kg/day dose of neem oil and the vehicle-control

    group. Similar results were obtained 30 days afterrecovery (Table 2).

    Effects on organ coefficient

    The results of organ coefficient are summarized in

    Table 3, the organ coefficient of heart, liver, spleen,

    lung and kidneys in the experimental groups with

    177, 533 and 1600 mg/kg/day dose of neem oil for

    90 days had no statistical difference compared with

    that of the vehicle-control group, the same result was

    also shown 30 days after recovery (p > 0.05).

    Histopathological findings

    At the 90th day, the histopathological examination

    showed that only the 1600 mg/kg/day dose of neemoil had varying degrees of damage on each organ

    except heart, uterus and ovary. The consistent

    treatment-related histopathological changes were

    found in both sexes.

    In the vehicle-control group (group I), the cross-

    section of liver showed normal appearance, hepatic

    artery, portal vein, bile duct, sinusoids (Sis) and hepato-

    cytes (Hs), all clearly conserved (Figure 1(a)). Doses

    (177 and 533 mg/kg/day) of groups II and III, respec-

    tively, only showed central venous and Sis congestion

    (d)(c)

    (b)(a)ST RP

    WP

    GC

    Figure 2. Effect of neem oil on the microstructures of spleen of mice after administration for 90 days. Panel A: group I(0 mg/kg, HE 200); panel B: group II (177 mg/kg, HE 400); panel C: group III (533 mg/kg, HE 400); panel D: group IV

    (1600 mg/kg, HE 400). Group I, the cross-section showed normal appearance of the spleen, spleen trabecula, RP, whitepulp, germinal centers, all clearly conserved. Groups II and III, showed the normal characteristic of spleen, infiltration ofmultinucleate giant cells in spleen (!); group IV, severe hyperemia of RP (") and infiltration of multinucleate giant cells (!)in spleen were observed. RP: red pulp.

    908 Human and Experimental Toxicology 32(9)

  • 7/29/2019 89658354

    6/11

    in liver lobule, Hs occurred granular and slight vacuolar

    degeneration (Figure 1(b) and (c)), while at the dose

    (1600 mg/kg/day dose) of group IV, central venous

    congestion, granular and vacuolar degeneration, karyor-

    rhexis were observed in Hs (Figure 1(d)).

    In group I, the cross-section of the spleen showednormal appearance, spleen trabecula, red pulp (RP),

    white pulp and germinal centers, all clearly conserved

    (Figure 2(a)). Groups II and III showed the normal

    characteristic of spleen associated with infiltration

    of multiple giant cells (Figure 2(b) and (c)), while

    in group IV severe hyperemia of RP and infiltration

    of multinucleate giant cells in spleen were observed

    (Figure 2(d)).

    In group I, the cross-section of the lung showednormal appearance (Figure 3(a)). In group II, the

    alveolar walls were thickened, the capillaries in the

    alveolar walls and interstitial were congested with

    many red blood cells (Figure 3(b)), while in groups III

    and IV, the alveolar walls were thickened, the capil-

    laries in the alveolar walls and interstitial were

    severely congested, a serious alveolar cavity hemor-rhage was observed (Figure 3(c) and (d)).

    In group I, the cross-section of the kidneys showed

    normal appearance, glomerulus and renal tubule

    structure was normal (Figure 4(a)). Groups II and III

    showed capillary of glomerulus and interstitial

    angiectasis hyperemia, renal tubular epithelial cells

    swelling, granular degeneration and some of them

    were separated from the basement membrane (Figure

    4(b) and (c)). In group IV, massive inflammatory cells

    especially neutrophilic granulocyte infiltrated in the

    (d)

    (b)

    (c)

    (a)

    A

    AS

    AD

    Figure 3. Effect of neem oil on the microstructures of lung of mice after administration for 90 days. Panel A: group I(0 mg/kg, HE 400); panel B: group II (177 mg/kg, HE 400); panel C: group III (533 mg/kg, HE 400); panel D: group IV

    (1600 mg/kg, HE 400). Group I, the cross-section showed the normal appearance of lung. Alveolus (A), alveolar ducts(AD), alveolar sac (AS), all clearly conserved. Group II, showed the alveolar walls were thickened ("), the capillaries in thealveolar walls and interstitial were congested with many red blood cells (!); groups III and IV, the alveolar walls werethickened ("), the capillaries in the alveolar walls and interstitial were severe congested, alveolar cavity hemorrhage seri-ous were observed (!).

    Wang C. et al. 909

  • 7/29/2019 89658354

    7/11

    glomeruli and nephric tubules, RETC degeneration

    and necrosis, segregated with basilar membrane. Therenal tubule revealed protein cast (Figure 4(d)).

    In group I, the cross-section showed the normal char-

    acteristic of testicle, the seminiferous tubules structurewas intact, all levels of spermatogenic cells (SCs) were

    arranged in order (Figure 5(a)). In Groups II andIII show-

    ing the decrease of SCs and blister degeneration, in some

    more serious cases, SCs occurs ballooning degeneration

    (Figure 5(b) and (c)). Group IV, the basic structure of

    seminiferous tubule was destroyed, SCs were seriously

    dissolved and disappeared, sperm within the seminifer-

    ous lumen almost completely disappeared (Figure 5(d)).

    Thirty days after recovery, the degree of injury to

    the tissues was lessened or even restored.

    Discussion

    Food consumption is a key parameter for determining

    the dose of feeding and an important indicator of toxic

    effects of chemical substances.18 The results obtained

    from the study demonstrated that the food consumptionof mice at the dose of 1600 mg/kg/day decreased very

    significantly in months 2 and 3, while those from the

    other experimental groups had no significant changes

    compared with the control group. And this was consis-

    tent with the general clinical manifestations observed

    and recorded for group IV, so the clinical dosage of

    neem oil should be lower than 1600 mg/kg/day.

    The results from the subchronic oral toxicity study

    with neem oil on male and female young adult mice

    Figure 4. Effect of neem oil on the microstructures of kidneys of mice after administration for 90 days. Panel A: group I(0 mg/kg, HE 200); panel B: group II (177 mg/kg, HE 400); panel C: group III (533 mg/kg, HE 400); panel D: group IV(1600 mg/kg, HE 400). Group I, the cross-section showed the normal appearance of kidney, glomerulus (G), proximaltubule (PT) and distal tubule (DT), all conserved. Groups II and III, capillary of renal interstitium was hemolysis (!), renaltubular epithelial cells swelling, granular degeneration, separated from basement membrane; group IV, massive inflamma-tory cells (#) infiltrated in the glomeruli and nephric tubules, RETC degeneration and necrosis, segregated with basilarmembrane. The renal tubule revealed protein cast.

    910 Human and Experimental Toxicology 32(9)

  • 7/29/2019 89658354

    8/11

    showed that all the serum biochemistry parameters of

    experimental groups had no statistically significant

    difference compared with those of the control group

    (p > 0.05) after oral administration with neem oil for

    90 days. Similar results were obtained 30 days after

    recovery. It indicated that oral administration of neem

    oil in mice for 90 days at and below 1600 mg/kg/daydose had no damage on the serum biochemistry para-

    meters. And this was consistent with the result of the

    studies of Rukmini et al. and Lakshminarayana.19,20

    Organ coefficient can reflect the degree of organs

    damages. Excluding the loss of water, age, gender, the

    effect of malnutrition and other factors before being

    weighed, the increase in the organ coefficient indi-

    cates that there are changes in congestion, edema,

    hyperplasia, hypertrophy in organs, while there are

    changes in shrink and degeneration when it is

    decreased.21 In the present study, all the examined

    organ coefficients had no statistical difference com-

    pared with those of the vehicle group, which indicated

    that neem oil had mild or no damages on organs of

    mice. And this was consistent with the result that the

    oral administration with neem oil for 90 days had

    varying degrees of damages on organs, but this waslessened or even to be restored 30 days after recovery.

    To determine the NOAEL and target organ toxicity

    of neem oil, the pathological examination of principal

    vital organs in mice at different doses of neem oil were

    observed under a microscope. The results of oral admin-

    istration with neem oil for 90 days from the study

    showed that neem oil had no damage on heart. The

    177 and 533 mg/kg/day doses of neem oil had mild

    damages on liver, spleen, lung, kidneys and testicle,

    such as slight vascular congestion, while 1600 mg/kg/

    (a)

    IC

    SzST

    St

    SC

    (b)

    SC

    ST

    (c)

    ST

    SC

    (d)

    ST

    SC

    Figure 5. Effect of neem oil on the microstructures of testicle of mice after administration for 90 days. Panel A: group I(0 mg/kg, HE 200); panel B: group II (177 mg/kg, HE 400); panel C: group III (533 mg/kg, HE 400); panel D: group IV

    (1600 mg/kg, HE 400). Group I, the cross-section showed the normal appearance of testicle, the seminiferous tubules,SCs at all levels, spermatozoon (Sz), testicular interstitial cells (IC) in stroma (St) surround the seminiferous tubules, allconserved. Groups II and III, the SCs abscission, quantity decrease, blister degeneration, serious turned into ballooningdegeneration; group IV, the basic structure of seminiferous tubule was destroyed, SCs were seriously dissolved and dis-appeared, sperm within the seminiferous lumen was almost completely disappeared. SC: spermatogenic cell.

    Wang C. et al. 911

  • 7/29/2019 89658354

    9/11

    day dose of neem oil had varying degrees of damages on

    each organ, mainly granular and vacuolar degeneration

    in cells and vascular congestion, in addition, in the lung,

    alveolar walls were thickened and hemorrhage damage

    was shown. All the damages on organs were lessened or

    even to be restored 30 days after recovery. So the patho-

    logic damage on mice with neem oil was reversible, thedamage may be gradually restored after thediscontinua-

    tion of treatment in the long run.

    In the present study, neem oil had mild damages on

    organs at a dose of 177 mg/kg/day, and the damages

    were restored after the discontinuation of treatment for

    30 days, so the NOAEL for males and females was con-

    sidered to be 177 mg/kg/day. The effect of neem oil on

    the liver, kidneys andtesticle was showing a good dose

    response relationship, indicating that the target organs

    of neem oil toxicity were the liver, kidneys and testicle.

    The testicle has been proved to be the target organ,which was consistent with the findings of Yin

    et al.22,23 The mechanism of the antifertility effect

    of extract chloroform from neem oil on mice maybe that the replacement process of testicular sperm

    nuclear protein was blocked, which led to abnormal

    epididymal sperm nucleoprotein and sperm not suffi-

    ciently differentiated to mature. Further study needed

    to do to explore the toxic mechanism of neem oil on

    liver and kidney.

    FundingThis work was supported by the Special Fund for Agro-

    scientific Research in the Public Interest (201203041);

    National Natural Science Foundation of China (Grant no.

    31272612); National Science & Technology Program in

    Rural Areas During the 12th Five Year Plan Period

    (2011BAD34B03-4); the Doctoral Program of Higher

    Education Research Fund (Instructor Dr Class

    20105103110001).

    Authors Note

    The first three authors contribute equally to this work and

    should be considered as first author. CW and MC contrib-uted equally to this work.

    Acknowledgments

    The authors thank Green Gold Biological Science & Tech-

    nology (Chengdu, PR China) for supplying neem oil.

    References

    1. Brahmachari G. Neem-an omnipotent plant: a retro-

    spection. Chem Biol Chem 2004; 5: 408421.

    2. Mitra CR. Neem. Indian Central Oil seeds Committee,

    Hyderabad, India, 1963, pp. 6994.

    3. Aggarwal SK and Dhawan VK. Some new medicinal

    properties of neem: a multipurpose farm forestry tree.

    India For 1995; 121: 10031005.

    4. Rukmini C. Chemical and nutritional evaluation of

    neem oil. Food Chem 1987; 26: 119124.

    5. Gosse B, Amissa AA, Adje FA, et al. Analysis of com-

    ponents of neem (Azadirachta indica) oil by diverse

    chromatographis techniques. J Liq Chromatogr Relat

    Technol 2005; 28: 22252233.

    6. SaxenaRC. Insecticides from neem. In: Arnason JT, Phi-

    logene BJR and Morand P (eds)Insecticides of plant ori-

    gin. ACS symposium series. Vol. 387. Washington, DC:

    American Chemical Society, 1989, pp. 110135.

    7. Mulla MS and Su T. Activity and biological effects of

    neem products against arthropods of medical and

    veterinary importance. J Am Mosquito Contr Assoc1999; 15: 133152.

    8. Biswas K, Chattopadhyay I, Banerjee RK, et al. Biolo-

    gical activities and medicinal properties of neem (Aza-

    dirachta indica). Curr Sci 2002; 82: 13361345.

    9. Du YH, Yin ZQ, Pu ZH, et al. Acaricidal activity of

    neem oil against Sarcoptes scabiei var. cuniculi larvae

    in vitro. Vet Sci 2007; 37: 10861089.

    10. Du YH, Jia RY, Yin ZQ, et al. Acaricidal activity of

    extracts of neem (Azadirachta indica) oil against the

    larvae of the rabbit mite sarcoptes scabiei var. cuniculi

    in vitro. Vet Parasitol 2008; 157: 144148.

    11. Du YH, Li JL, Yin ZQ, et al. Acaricidal activity of four

    fractions and octadecanoic acid-tetrahy-drofuran-3,

    4-diyl ester isolated from chloroform extracts of neem

    (Azadirachta indica) oil against Sarcoptes scabiei var.

    cuniculi larvae in vitro. Vet Parasitol 2009; 163:

    175178.

    12. Xu J, Fan QJ, Yin ZQ, et al. The preparation of neem

    oil microemulsion (Azadirachta indica) and the com-

    parison of acaricidal time between neem oil microe-

    mulsion and other formulations in vitro. Vet

    Parasitol 2010; 169: 399403.

    13. Zhang YQ, Xu J and Yin ZQ Isolation and identifica-tion of the antibacterial active compound from petro-

    leum ether extract of neem oil. Fitoterapia 2010; 81:

    747750.

    14. Yin ZQ. Study on the isolation, purification, identifica-

    tion and contraception mechanism of antifertility

    bioactive component from neem oil. PhD Thesis,

    Sichuan University, China, 2004.

    15. Shi DX, Yang F, Yin ZQ, et al. Study on the acute and

    accumulative toxicity of neem oil in mice. Vet Sci

    2010; 40: 317320.

    912 Human and Experimental Toxicology 32(9)

  • 7/29/2019 89658354

    10/11

    16. Organization for Economic Cooperation and Develop-

    ment. OECD guideline for testing of chemicals, 408.

    Repeated dose 90-day oral toxicity study in rodents.

    Paris, France: OECD, 1998.

    17. Lincopan N, Mamizuka EM and Carmona-Ribeiro A.

    Low nephrotoxicity of an effective amphotericin B for-

    mulation with cationic bilayer fragments. J Antimicrob

    Chemother 2005; 55: 727734.

    18. State Environmental Protection Administration.

    Testing of Chemicals. Beijing, China: China Environ-

    mental Science Press, 2004, pp. 497502.

    19. Rukmini C, Rao PU and Raychaudhuri SP. Chemi-

    cal composition and biological evaluation of debit-

    terised neem oil and neem cake. In: Recent

    advances in medicinal, aromatic and spice crops.

    International conference , New Delhi, India, 1991,

    pp. 191196.

    20. Lakshminarayana G. Potential of some unconventional

    vegetable oils for edible use. Proc Nutri Soci India

    1987; 33: 3848.

    21. Wang ZG. Experimental research on long term toxicity

    of reducing fever and bile expelling tablet. Acta Chin

    Med Pharmacol 2005; 33: 3840.

    22. Yin ZQ, Jia RY, Chen ZB, et al. The anti-fertility

    effect of extract chloroform from neem Oil on male

    mice. Scientia Silvae Sinicae 2005; 41: 124126.

    23. Yin ZQ, Zhang XS, Wu CK, et al. Approach on the

    anti-fertility effect and the mechanism of action of the

    compound of neem oil on female mice. Reprod Con-

    tracept 2006; 26: 146147.

    Wang C. et al. 913

  • 7/29/2019 89658354

    11/11

    C o p y r i g h t o f H u m a n & E x p e r i m e n t a l T o x i c o l o g y i s t h e p r o p e r t y o f S a g e P u b l i c a t i o n s , L t d .

    a n d i t s c o n t e n t m a y n o t b e c o p i e d o r e m a i l e d t o m u l t i p l e s i t e s o r p o s t e d t o a l i s t s e r v w i t h o u t

    t h e c o p y r i g h t h o l d e r ' s e x p r e s s w r i t t e n p e r m i s s i o n . H o w e v e r , u s e r s m a y p r i n t , d o w n l o a d , o r

    e m a i l a r t i c l e s f o r i n d i v i d u a l u s e .